Regression estimates and incidence rate ratios from GLMER for number of papers (top) and coauthors (bottom). by William C. Barley (8915282)

Subjects:

Distribution of continuous variables of all 3 visits of group 1 (placebo) and group 2 (placebo) that have no significant difference among the groups. by Nattapon Riengvirodkij (11268720)

Subjects:

Map of Zimbabwe highlighting the districts detected as persistent hotspots of <i>S. haematobium</i> prevalence (PPHS), persistent hotspots of decreased praziquantel efficacy (EPHS)... by Takafira Mduluza (39754)

<i>Ctsz</i>^{<i>−/−</i>} mice have higher lung burden and earlier spleen dissemination during acute infection followed by greater chronic inflammation and mortality risk.... by Rachel K. Meade (22216529)

S2 File - Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Va... by Sonsawan Sangprasert (22772538)

Box plots showing baseline prevalence and mean egg count at pre-MDA1 in districts that were responders compared to those that were persistent hotspots of decreasing praziquantel ef... by Takafira Mduluza (39754)

A. Representative data of NB4 cells (treated with LPS and RSV) ETOsis percentage by Flow cytometry method. NB4 cells are stimulated with LPS (1). NB4 cells are treated with 5 µ M R... by Mahshid Vafajoo (21144147)

Subjects:

Supporting information. by Yu Sang Choi (22656230)

Subjects:

PCoA plot analysis for dissimilarity. by Yu Sang Choi (22656230)

Subjects:

Composition of the gut microbiota at the genus level following the administration of MP. by Yu Sang Choi (22656230)

Subjects:

Disruption of hepatic metabolism in Lep KO mice. by Yu Sang Choi (22656230)

Subjects:

Composition of the gut microbiota at the phylum level following the administration of MP. by Yu Sang Choi (22656230)

Subjects:

Comparison of (a) Chao index and (b) Shannon diversity index of the fecal microbiota in WT and Lep KO mice. by Yu Sang Choi (22656230)

Subjects:

Comparison of Analgesic Consumption by WHO Analgesic Level Between 2023 and 2022. by Myriam Aïche (22290591)

Subjects:

Demographic and Clinical Characteristics of Children Exposed or Not Exposed to the Fear Self-Assessment Tool (Trouillomètre®). by Myriam Aïche (22290591)

Subjects:

Multivariate Linear Regression Analysis of Factors Associated with Pain Scores (VAS) in Children Aged 7–12. by Myriam Aïche (22290591)

Subjects:

Flow chart. by Myriam Aïche (22290591)

Subjects:

Linear regression. by Myriam Aïche (22290591)

Subjects:

Comparison of Pain Scores (VAS) Between Children Exposed and Not Exposed to the Fear Self-Assessment Tool (Trouillomètre®). by Myriam Aïche (22290591)

Subjects:

Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. by Farrokh Habibzadeh (12256529)